Search & Analyze
Popular Searches
Jagsonpal Pharmaceuticals Ltd.
Healthcare₹222.202.02%
24 Jul, 4:01 PM
CMP₹222.20
Mkt Cap₹1.44K Cr
P/E33.34
P/B6.05
ROE28.51%
52W High₹301.80
52W Low₹154.90
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
33.34
P/B Ratio
6.05
EV/EBITDA
18.98
Price/Sales
5.00
Dividend Yield (%)
1.84
EPS (TTM ₹)
6.53
Book Value (₹)
36.03
ROE (%)
28.51
ROCE (%)
33.14
ROA (%)
21.44
EBITDA Margin (%)
18.12
Net Profit Margin (%)
19.65
Debt/Equity
0.00
Current Ratio
6.22
Interest Coverage
73.92
Asset Turnover
1.09
Working Capital/Sales
2.08
Core EBITDA Growth (%)
83.21
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 18794.56 | 2175.84 | 2367.14 | 2087.02 | 2687.16 |
| Net Sales | 18794.56 | 2175.84 | 2367.14 | 2087.02 | 2687.16 |
| Total Income | 19233.89 | 2210.11 | 2424.48 | 2179.81 | 2769.06 |
| Total Expenditure | 16886.71 | 1925.58 | 2025.62 | 1856.35 | 2176.45 |
| Operating Profit | 2347.18 | 284.53 | 398.86 | 323.46 | 592.61 |
| Depreciation | 108.6 | 15.26 | 12.05 | 16.63 | 81.31 |
| Exceptional Items | — | — | -34.59 | — | 196.87 |
| Profit Before Tax | 2187.23 | 266.42 | 348.09 | 298.69 | 698.59 |
| Tax | 481.4 | 77.87 | 80.88 | 74.06 | 144.98 |
| Profit After Tax (PAT) | 1705.83 | 188.55 | 267.21 | 224.63 | 553.61 |
| EPS (₹) | 6.51 | 7.2 | 10.2 | 3.4 | 8.26 |
| Dividend Payout % | 20 | 80 | 100 | 100 | 125 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 1309.9 | 130.99 | 130.99 | 132.19 | 132.8 |
| Reserves | 10883.01 | 1196.6 | 1370.26 | 1571.13 | 2047.05 |
| Shareholders Funds | 12192.91 | 1327.59 | 1588.9 | 1874.02 | 2399.5 |
| Total Debt | 678.79 | 0 | 0 | 0 | 0 |
| Total Liabilities | 16420.24 | 1713.96 | 2025.59 | 2246.38 | 2918.32 |
| Total Assets | 16420.24 | 1713.96 | 2025.59 | 2246.38 | 2918.32 |
| Book Value / Share | 43.5491 | 50.6752 | 57.304 | 64.427 | 32.8291 |
| Assets | 16420.24 | 1713.96 | 2025.59 | 2246.38 | 2918.32 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 2822.24 | 69.14 | 466.55 | 351.66 | 553 |
| Investing Activities | -226.43 | -257.79 | -576.71 | -245.48 | -451.47 |
| Financing Activities | -682.82 | -175.52 | -4.57 | -89.11 | -116.98 |
| Net Cash Flow | 1912.99 | -364.17 | -114.73 | 17.07 | -15.45 |
JAGSNPHARM
₹222.20
+2.02%